Skip to main content
. 2020 May 29;28(3):249–271. doi: 10.3727/096504019X15766663541105

Figure 4.

Figure 4

Figure 4

Above and facing page. Comparison of OS by demographic and clinical parameters. No difference of OS among primary hepatocellular carcinoma (HCC) patients, primary intrahepatic cholangiocarcinoma (ICC) patients, and secondary liver cancer patients was observed (A), and patients with largest nodule size ≥5 cm (J), portal vein invasion (K), Child–Pugh stage B + C (O), or Barcelona Clinic Liver Cancer (BCLC) stage C + D (Q) had worse OS. No other difference was discovered between/among the remaining subgroups (B–I, L–N, P, R–Z). Comparison of OS between/among groups was determined by Kaplan–Meier (K-M) curves and log-rank test. A value of p < 0.05 was considered significant.